12/16/2022 6:45:10 AM
Diffusion Pharma Enters Settlement Agreement With LifeSci Special Opportunities
12/5/2022 6:54:58 AM
Diffusion Urges Stockholders To Vote "FOR" Each Of Board's Six Nominees For Director On WHITE Proxy Card
11/10/2021 7:24:59 AM
Diffusion Pharma Q3 Loss Per Share $0.12 Vs Loss $0.07 Last Year
6/18/2021 7:41:58 AM
Diffusion Reminds Stockholders To Vote On Proposals Listed In Proxy Statement
3/18/2021 7:07:41 AM
Diffusion Doses First Participants In TCOM Study
2/11/2021 10:05:34 PM
Diffusion Pharma Increases Bought Deal Offering Of Common Stock To $30 Mln